Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A prospective multicenter randomized controlled pivotal trial to evaluate the safety and effectiveness of transcatheter mitral valve repair with the Edwards PASCAL

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Mitral Valve Regurgitation
  • Age: Between 18 Year(s) - 110 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    CLASP IID Cohort:
    1. Participants who are minimum of 18 years of age and able to provide informed consent
    2. Those at prohibitive risk for mitral valve surgery by a heart team
    3. A candidate for transcatheter mitral valve repai

You may not be eligible for this study if the following are true:

  • CLASP IID Cohort:
    1. Those for who a TEE is contraindicated or screening TEE is unsuccessful
    2. Mitral valve anatomy which may preclude proper PASCAL System or MitraClip System access, use and/or deployment or sufficient reduction in mi

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.